Delivery Order SPE2DB22D2006-SPE2DB23FV9HD
Award Date 4/25/23
Potential Completion Date 4/26/23
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 80 mg/0.8 mL pens. The contract has a ceiling value of $5,354.56 and a completion date of December 13, 2024. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Humira (adalimumab) pens to the Defense Logistics Agency (DLA). The $4,182.73 delivery order is a firm-fixed-price contract with an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,980.64, is for the provision of Humira (adalimumab) pen medication. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,158.74 firm fixed-price contract is for the supply of the medication Humira (adalimumab) in a prefilled pen form. The contract has a performance period through July 2024 and is not a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for providing a wide range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humira (adalimumab) pens. The $22,850.20 firm fixed-price contract has an ultimate completion date of August 20, 2024. AmerisourceBergen is delivering this product under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a wide range of medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,549.45, is for the delivery of Humira (adalimumab) prefilled pens for the U.S. government, with an ultimate completion date of October 26, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) injector pens. The $3,496.44 firm-fixed-price contract has a completion date of September 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
- This federal contract award to Amerisourcebergen Drug Corp. is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of 4,566,133,629 units of HUMIRA PEN 40 MG/0.8 MLS, a specialty pharmaceutical product, at a ceiling value of $2,770.74. The contract is a firm fixed-price arrangement without any set-aside requirements, indicating open...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Humira (adalimumab) autoinjector pens. The $17,895.40 contract has a completion date of May 20, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Humira (adalimumab) auto-injector pens, a specialty medication used to treat certain chronic conditions. The contract has a ceiling value of $1,385.37 and is a firm-fixed-price delivery order, with a period of performance through May 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery...